ALK and inflammatory myofibroblastic tumor: This report describes the importance of comprehensive molecular testing in anaplastic lymphoma kinase‐negative inflammatory myofibroblastic tumour (IMT) and demonstrates that complete surgical resection can achieve excellent outcomes even in rapidly growing IMT.